Pelthos Therapeutics (PTHS) Selling, General & Administrative (2023 - 2026)
Pelthos Therapeutics' Selling, General & Administrative was $27.67 million in Q2 2026, up 918.9% from $2.72 million a year earlier and up 31.1% from the prior quarter.
Powered by 
Analysis
Pelthos Therapeutics (PTHS) Selling, General & Administrative (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Pelthos Therapeutics' Selling, General & Administrative was $86.87 million through Jun 30, 2026; for FY2025, it came in at $42.45 million, up 564.2% from FY2024.
- Selling, General & Administrative has now increased for three consecutive years, with a three-year compound annual growth rate of 238.1% (FY2022 to FY2025).
- In earlier years, Selling, General & Administrative was $6.39 million in FY2024 (+133.4%), $2.74 million in FY2023 (+149.3%) and $1.1 million in FY2022.
- The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q1 2023.
- Per Business Quant data, PTHS's Selling, General & Administrative in the three quarters before Q2 2026 was $21.1 million (Q1 2026), $18.47 million (Q4 2025) and $19.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Pelthos Therapeutics | 77.24 Mn | -11.16 Mn | 11.99 Mn | 27.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.67 Mn |
| Mar 31, 2026 | 21.10 Mn |
| Dec 31, 2025 | 18.47 Mn |
| Sep 30, 2025 | 19.63 Mn |
| Jun 30, 2025 | 2.72 Mn |
| Mar 31, 2025 | 1.64 Mn |
| Dec 31, 2024 | 1.54 Mn |
| Sep 30, 2024 | 1.63 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 787,561.00 |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 661,572.00 |
| Jun 30, 2023 | 537,876.00 |
| Mar 31, 2023 | 477,630.00 |
API Access
Pelthos Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PTHS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "PTHS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PTHS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();